Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The Ministry of Defence (MoD) are considering a requirement to develop a Tranexamic Acid Auto-Injector (TXA AI) containing 500mg/5ml formulation as soon as is technically possible, to reduce the need for clinical trials and gain UK MoD approval for off licence use. The UK MoD may subsequently seek an AI containing an improved formulation of TXA, by increasing concentration and reducing volume.
No supplier information available.